These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 3051233)

  • 1. Treatment by protocol: assessment of gains and losses.
    Scheurlen H
    Recent Results Cancer Res; 1988; 111():87-94. PubMed ID: 3051233
    [No Abstract]   [Full Text] [Related]  

  • 2. Analysis of survival in cancer clinical trials.
    Shimm D; Logue G
    Ann Intern Med; 1983 May; 98(5 Pt 1):665-6. PubMed ID: 6846980
    [No Abstract]   [Full Text] [Related]  

  • 3. Statistical standards for protocols and protocol deviations.
    Lewis JA
    Recent Results Cancer Res; 1988; 111():27-33. PubMed ID: 3175309
    [No Abstract]   [Full Text] [Related]  

  • 4. Failing to improve overall survival because post-protocol survival is long: fact, myth, excuse or improper study design?
    Prasad V; Vandross A
    J Cancer Res Clin Oncol; 2014 Apr; 140(4):521-4. PubMed ID: 24474554
    [No Abstract]   [Full Text] [Related]  

  • 5. Eligibility exclusions, losses to follow-up, removal of randomized patients, and uncounted events in cancer clinical trials.
    Gail MH
    Cancer Treat Rep; 1985 Oct; 69(10):1107-13. PubMed ID: 4042091
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Statistical properties and use of sequential methods in randomized clinical trials when the response criterion is censored.
    Bénichou J; Chastang C
    Recent Results Cancer Res; 1988; 111():207-15. PubMed ID: 3175307
    [No Abstract]   [Full Text] [Related]  

  • 7. [Some proposals to cancer clinical trials in Japan--a biostatistician's view].
    Oh-hashi Y
    Gan To Kagaku Ryoho; 1993 Dec; 20(16):2483-95. PubMed ID: 8279846
    [No Abstract]   [Full Text] [Related]  

  • 8. Size of phase III cancer clinical trials.
    Simon R
    Cancer Treat Rep; 1985 Oct; 69(10):1087-93. PubMed ID: 4042088
    [No Abstract]   [Full Text] [Related]  

  • 9. [Report from the colloquium on long-term clinical trial strategies].
    Sakamoto J; Nakazato H
    Gan To Kagaku Ryoho; 1990 Apr; 17(4 Pt 1):701-8. PubMed ID: 2138874
    [No Abstract]   [Full Text] [Related]  

  • 10. The use of data bases and historical controls in treatment comparisons.
    Byar DP
    Recent Results Cancer Res; 1988; 111():95-8. PubMed ID: 3175313
    [No Abstract]   [Full Text] [Related]  

  • 11. Knowledge engineering for a clinical trial advice system: uncovering errors in protocol specification.
    Musen MA; Rohn JA; Fagan LM; Shortliffe EH
    Bull Cancer; 1987; 74(3):291-6. PubMed ID: 3620734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The scientific basis of clinical trials: statistical aspects.
    Gehan EA
    Clin Cancer Res; 1997 Dec; 3(12 Pt 2):2587-90. PubMed ID: 9815661
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative clinical trials with historical controls: a statistician's view.
    Gehan EA
    Biomedicine; 1978 Sep; 28 Spec No():13-9. PubMed ID: 363189
    [No Abstract]   [Full Text] [Related]  

  • 14. Policies for interim analysis and interim reporting of results.
    O'Fallon JR
    Cancer Treat Rep; 1985 Oct; 69(10):1101-6. PubMed ID: 4042090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Centralised treatment, entry to trials and survival.
    Stiller CA
    Br J Cancer; 1994 Aug; 70(2):352-62. PubMed ID: 8054285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Use of prognostic knowledge in the planning and analysis of randomized therapeutic trials].
    Byar D; Chastang C
    Bull Cancer; 1987; 74(2):177-84. PubMed ID: 3607300
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical trials for clinicians.
    Gelber RD; Goldhirsch A
    Chest; 1989 Jul; 96(1 Suppl):97S-101S. PubMed ID: 2737006
    [No Abstract]   [Full Text] [Related]  

  • 18. [Design consideration for clinical trials].
    Flemming TR
    Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 1):568-73. PubMed ID: 3355178
    [No Abstract]   [Full Text] [Related]  

  • 19. Limitations and advantages of meta-analysis in clinical trials.
    Rockette HE; Redmond CK
    Recent Results Cancer Res; 1988; 111():99-104. PubMed ID: 3175314
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical trials--time for a paradigm shift?
    Bradley C
    Diabet Med; 1988 Mar; 5(2):107-9. PubMed ID: 2964973
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.